The HCMV Chemokine Receptor US28 is a Potential Target in Vascular Disease
Current Drug Target -Infectious Disorders · 2001
DOI: 10.2174/1568005014606080 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Drug Target -Infectious Disorders, 2001. Verfasst von D N Streblow und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology and Immunology, Vaccine and Gene Therapy Institute, Oregon Health Sciences University, Portland, OR 97201, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Microbiology and Immunology, Vaccine and Gene Therapy Institute, Oregon Health Sciences University, Portland, OR 97201, USA.
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Streblow, D. N., Orloff, S. L., & Nelson, J. A. (2001). The HCMV Chemokine Receptor US28 is a Potential Target in Vascular Disease. Current Drug Target -Infectious Disorders. https://doi.org/10.2174/1568005014606080
Vancouver
Streblow DN, Orloff SL, Nelson JA. The HCMV Chemokine Receptor US28 is a Potential Target in Vascular Disease. Current Drug Target -Infectious Disorders. 2001. doi:10.2174/1568005014606080
BibTeX
@article{Streblow2001,
author = {Streblow, D N and Orloff, S L and Nelson, J A},
title = {The HCMV Chemokine Receptor US28 is a Potential Target in Vascular Disease},
journal = {Current Drug Target -Infectious Disorders},
year = {2001},
doi = {10.2174/1568005014606080}
}
EUVIMED